You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prothionamide

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
  • +37 more
Oct 11, 2023

Antiretroviral Drugs and Related Drugs During and After

Completed
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +61 more
Jun 28, 2022

Tuberculosis Trial in Beijing (Total oral short-term therapy that includes linezolid, bedaquiline and/or cycloserine.)

Unknown status
  • Tuberculosis
  • Total oral short-term therapy that includes linezolid, bedaquiline and/or cycloserine.
  • Beijing, Beijing, China
    Beijing Chest Hospital affiliated to Capital Medical University
Sep 11, 2020

Multi-drug Resistant Tuberculosis Trial in Lambarene (Km+ Mfx+ Pto + H + Cfz +E+Z)

Recruiting
  • Multi-drug Resistant Tuberculosis
  • Km+ Mfx+ Pto + H + Cfz +E+Z
  • Lambarene, Please Select, Gabon
    Centre de Recherches Médicales de Lambaréné
Jul 26, 2021

Multidrug Resistant Tuberculosis Trial in China (PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter

Recruiting
  • Multidrug Resistant Tuberculosis
  • PZA sensitivity guided ultra-short all Oral Regimen
  • Standardized Shorter Regimen
  • Shenzhen, Guangzhou, China
  • +13 more
Jul 22, 2020

Pulmonary Tuberculosis TB in Sputum: (+) Microscopy Trial in Shanghai (Group A (the standard 2HRZE/4HR regimen), Group B (New

Completed
  • Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
  • Group A (the standard 2HRZE/4HR regimen）
  • Group B (New short course PRS regimen, 4EZ(high dose)PtoCfz)
  • Shanghai, China
  • +3 more
Nov 5, 2020

Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)

Not yet recruiting
  • Tuberculosis, Multidrug-Resistant
  • Targeted sequencing using the GenoScreen Deeplex assay
  • Cape Town, Western Cape, South Africa
    University of Cape Town
Sep 28, 2021

Cardiovascular Diseases, Coronary Disease, Heart Diseases Trial (aspirin, carotene)

Completed
  • Cardiovascular Diseases
  • +3 more
  • (no location specified)
Jan 26, 2021

Multidrug Resistant Tuberculosis Trial in China (WHO-approved MDR-TB regimen, NGS-guided regimen: Regimen A, NGS-guided regimen:

Not yet recruiting
  • Multidrug Resistant Tuberculosis
  • WHO-approved MDR-TB regimen
  • +3 more
  • Shenzhen, Guangzhou, China
  • +11 more
Jul 19, 2018

Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs

Completed
  • Tuberculosis
  • Saliva sampling
  • Plasma/serum sampling
  • Haren, Groningen, Netherlands
    University Medical Center Groningen (UMCG) Beatrixoord
Nov 20, 2018

Tuberculosis Multi Drug Resistant Active Trial (Delamanid, Linezolid, Levofloxacin)

Withdrawn
  • Tuberculosis Multi Drug Resistant Active
  • (no location specified)
Sep 7, 2017

MDR TB Trial in Nanjing (RhIL-2)

Unknown status
  • MDR TB
  • Nanjing, Jiangsu, China
    the First Affiliated Hospital of Nanjing Medical University
Feb 27, 2017

Simplified Short Regimen for Multidrug Resistant Tuberculosis in

Unknown status
  • Multidrug Resistant Tuberculosis
  • Short course MDR-TB treatment regimen
  • Nukus, Karakalpakstan, Uzbekistan
    Outpatient clinics in three districts
Jul 9, 2015

Healthy Trial in Seoul (Levofloxacin and Streptomycin added, Moxifloxacin and Kanamycin added)

Completed
  • Healthy
  • Levofloxacin and Streptomycin added
  • Moxifloxacin and Kanamycin added
  • Seoul, Korea, Republic of
    Seoul National University Bundang Hospital
Apr 29, 2014

Multidrug Resistant Tuberculosis Trial in China (Pyrazinamide containing regimen, Regimen without Pyrazinamide)

Unknown status
  • Multidrug Resistant Tuberculosis
  • Pyrazinamide containing regimen
  • Regimen without Pyrazinamide
  • Chongqing, Chongqing, China
  • +10 more
Apr 21, 2014